Who owns UNICYCIVE THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Unicycive Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Unicycive Therapeutics stock

Who bought or sold UNICYCIVE THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vivo Capital 1.8M $10M 0% Dec 2025
 View chart
Octagon Capital Advisors 1.0M $5.8M 0% Dec 2025
 View chart
Nantahala Capital Management 939k $5.4M 0% Dec 2025
 View chart
Dr. Jeffrey R. Jay, M.D. 797k $4.6M 0% Dec 2025
 View chart
Vanguard Group 789k $4.6M 20% Dec 2025
 View chart
Logos Global Management 474k $2.7M 0% Dec 2025
 View chart
Cantor Fitzgerald, L. P. 200k $1.2M 100% Dec 2025
 View chart
Geode Capital Management 171k $989k 36% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 100k $576k 181249% Dec 2025
 View chart
Dauntless Investment Group 89k $516k 100% Dec 2025
 View chart
OMERS Administration Corporation 78k $451k 100% Dec 2025
 View chart
State Street Corporation 65k $376k 19% Dec 2025
 View chart
Longwood Capital Partners 60k $346k 0% Dec 2025
 View chart
Squarepoint Ops 55k $319k -53% Dec 2025
 View chart
Susquehanna International 51k $296k 100% Dec 2025
 View chart
Citadel Advisors 42k $182k 100% Sep 2025
 View chart
Quadrature Capital 39k $226k 100% Dec 2025
 View chart
BlackRock 36k $210k 0% Dec 2025
 View chart
Northern Trust 36k $207k 10% Dec 2025
 View chart
XTX Topco 35k $204k -6% Dec 2025
 View chart
Cubist Systematic Strategies 24k $104k 100% Sep 2025
 View chart
Chicago Partners Investment 22k $155k -17% Dec 2025
 View chart
Jane Street 21k $121k 100% Dec 2025
 View chart
UBS Group 20k $115k 266% Dec 2025
 View chart
Tower Research Capital 1.9k $11k 100% Dec 2025
 View chart
SBI Securities 558.00 $3.2k 0% Dec 2025
 View chart
Rockefeller Capital Management 500.00 $2.9k 0% Dec 2025
 View chart
TFC Financial Management 300.00 $1.7k 0% Dec 2025
 View chart
Harbour Investments 100.00 $577.000000 0% Dec 2025
 View chart
Barclays 80.00 $462.000000 0% Dec 2025
 View chart
Bogart Wealth 6.00 $34.999800 0% Dec 2025
 View chart
Danske Bank A/s 1.00 $6.000000 0% Dec 2025
 View chart

Who sold out of Unicycive Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Goldman Sachs Group Sep 2025 45k $197k
Fortitude Family Office Sep 2025 107.00 $467.001500